Isabel Portero

CEO & Founder
Biohope

Doctor in Medicine and specialist in Internal Medicine, with a solid experience in the development of innovation in Biomedicine. Her biotech company has designed and patented several innovative diagnostic tests that, for the first time, allow Personalized Medicine to be applied to immunological diseases and organ transplants. Biohope's ambition is for all patients to receive personalized medical treatment based on their individual physiology. Their first product is Immunobiogram®, aimed at personalizing treatment for kidney transplant patients. They long to make a contribution to medicine and to lead a professional team that could make a school based on business ethics and innovation.